Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species

Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species

US Patent 9382252 · Granted Jul 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating patients suffering from a disease condition or disorder that2025
Process for preparing solutions comprising biopterin derivatives2025
Methods of treating patients suffering from brain injury and methods of increasi2024
Solid pharmaceutical compositions comprising biopterin derivatives and uses of s2023
Solid pharmaceutical compositions comprising biopterin derivatives and uses of s2021
Solid pharmaceutical compositions comprising biopterin derivatives and uses of s2019
Solid pharmaceutical compositions comprising biopterin derivatives and uses of s2018
Solid pharmaceutical compositions comprising biopterin derivatives and uses of s2018
Use of pteridine derivatives for the treatment of increased intracranial pressur2016
Use of pteridine derivatives for the treatment of increased intracranial pressur2016
Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and2012
Use of pteridine derivatives for the treatment of increased intracranial pressur2012